ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Three Drug Majors Back Start-Up Enlight

July 14, 2008 | APPEARED IN VOLUME 86, ISSUE 28

Merck & Co., Pfizer, and Eli Lilly & Co. are the founding members of Enlight Biosciences, a new Boston-based company that seeks to advance technologies that accelerate drug discovery and development. Conceived by the three drug companies and the venture firm PureTech Ventures, Enlight will start with $39 million in funding. The partners note that most life sciences investors in recent years have focused on late-stage therapeutic programs to the detriment of new technology.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment